Aurora Cannabis (ACB) Misses Q3 EPS by 7c

Aurora Cannabis (NASDAQ: ACB) reported Q3 EPS of (Cdn$0.17), Cdn$0.07 worse than the analyst estimate of (Cdn$0.10). Revenue for the quarter came in at Cdn$46.26 million, versus Cdn$60.11 million reported last year.

For earnings history and earnings-related data on Aurora Cannabis (ACB) click here.

You May Also Be Interested In

• Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Morgan Stanley course-corrects their semiconductor equipment outlook on demand